66-Year-old woman with painless vesicular lesions

Mayo Clinic Proceedings

Volumn 84, Issue 7, 2009, Pages 639-642

  Bardia, Aditya ^a   Swanson, Elizabeth A ^a   Thomas, Kris G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PORPHYRIN;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; ERYTHEMA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; SKIN BIOPSY; URINALYSIS; VESICULAR RASH; FINGER; METABOLISM;

AGED; FEMALE; FINGERS; HUMANS; PORPHYRIA CUTANEA TARDA;

EID: 67650727948     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/84.7.639     Document Type: Article

References (20)

1. Berger TG. Dermatologic disorders. In: Current Medical Diagnosis and Treatment 2008. 47th ed. McPhee SJ, Papadakis MA, Tierney LM Jr, eds. New York, NY: McGraw-Hill Companies; 2008:104-108.
2. Rich MW. Porphyria cutanea tarda: don't forget to look at the urine. Postgrad Med. 1999;105(4):208-210, 213-214.
3. Deacon AC, Elder GH. ACP Best Practice No 165: front line tests for the investigation of suspected porphyria. J Clin Pathol. 2001;54:500-507.
4. Poulin V, Chopra A, Tefferi A. 80-year-old man with anemia and blistering skin lesions. Mayo Clin Proc. 2004;79(9):1181-1184.
5. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology. 1998;27(6):1661-1669.
6. Gibson GE, McEvoy MT. Coexistence of lupus erythematosus and porphyria cutanea tarda in fifteen patients. J Am Acad Dermatol. 1998;38(4):569-573.
7. Schanbacher CF, Vanness ER, Daoud MS, Tefferi A, Su WP. Pseudoporphyria: a clinical and biochemical study of 20 patients. Mayo Clin Proc. 2001;76(5):488-492.
8. Sassa S. Modern diagnosis and management of the porphyrias. Br J Haematol. 2006 Nov;135(3):281-292. Epub 2006 Sep 4.
9. Sweeney GD, Jones KG. Porphyria cutanea tarda: clinical and laboratory features. Can Med Assoc J. 1979;120(7):803-807.
10. Sassa S, Shibahara S. Disorders of heme production and catabolism. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:1435-1502.
11. Murphy GM; British Photodermatology Group. The cutaneous porphyrias: a review. Br J Dermatol. 1999;140(4):573-581.
12. Waldenström J. Studien über porphyrie. Acta Med Scand Suppl. 1937;82:1-254.
13. Lambrecht RW, Thapar M, Bonkovsky HL. Genetic aspects of porphyria cutanea tarda. Semin Liver Dis. 2007;27(1):99-108.
14. Siersema PD, ten Kate FJ, Mulder PG, Wilson JH. Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence. Liver. 1992;12(2):56-61.
15. Lundvall O. Phlebotomy treatment of porphyria cutanea tarda. Acta Derm Venereol Suppl (Stockh). 1982;100:-107-118.
16. Grossman ME, Bickers DR, Poh-Fitzpatrick MB, Deleo VA, Harber LC. Porphyria cutanea tarda: clinical features and laboratory findings in 40 patients. Am J Med. 1979;67(2):277-286.
17. Köstler E, Wollina U. Therapy of porphyria cutanea tarda. Expert Opin Pharmacother. 2005;6(3):377-383.
18. Anderson KE, Goeger DE, Carson RW, Lee SM, Stead RB. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis [published correction appears in N Engl J Med. 1990;322(22):1616]. N Engl J Med. 1990;322(5):315-317.
19. Sarkany RP. The management of porphyria cutanea tarda. Clin Exp Dermatol. 2001;26(3):225-232.
20. Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Borghi A, Ventura E. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda. J Lab Clin Med. 1986;107(1):36-42.